VIDEO: Directional deep brain stimulation: novel treatment options for all Parkinson’s patients
sponsored by Boston Scientific
Author: SPONSOREDPublished: 4 October 2017
Prep: Cook: Serves:
Watch deep brain stimulation (DBS) experts Professor Pollo, Professor Timmermann, Professor Visser-Vanderwalle and Professor Volkmann explain the benefits of novel directional DBS systems for improved symptom control and fewer side effects
Every human brain is unique and every course of Parkinson’s disease has its own characteristics. In deep brain stimulation (DBS) therapy, physicians aim to target a very specific part of the brain – the subthalamic nucleus – in order to mitigate Parkinson’s symptoms.
Up until now, conventional DBS systems only allowed for stimulation with ring electrodes. With these electrodes, stimulation took the form of a ring around the electrode in the lead that was implanted into the patient’s brain. This meant that while physicians tried to target a very specific area of the brain, they always ran the risk of stimulating its neighbouring regions – since they could not steer the stimulation precisely. Unintended and unwanted stimulation could cause side effects such as speech problems.
The latest generation of DBS devices allow physicians to precisely steer the stimulation to target one specific area of the brain – significantly reducing side effects from unwanted stimulation. Our directional DBS systems use novel lead designs with segmented electrodes that allow the activation of individual electrode contacts. In addition, the technology in the pulse generator that powers the leads – the Multiple Independent Current Control (MICC) technology – allows the physician to specify exactly the amount of current needed for every contact of the electrode.
Through activating specific electrode contacts, and defining the amount of stimulation for each contact, stimulation precision is significantly increased. It is similar to shining a light on a specific spot with a flashlight. With the new systems, physicians now have full control of the stimulation steering and an increased set of stimulation options.
About deep brain stimulation (DBS) therapy
DBS uses a stimulator that is implanted into the patient’s chest. The stimulator sends mild electrical impulses to specific areas of the brain via thin wires called leads. This stimulation may help improve day-to-day experiences for people living with movement disorders such as Parkinson’s disease, dystonia, or essential tremor.
For comprehensive information on deep brain stimulation and Parkinson’s, please visit the EPDA website.
This article is sponsored by Boston Scientific. The information in this article is given for information purposes only and does not represent an endorsement by the EPDA of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided.
Is Obama’s ‘Cures Act’ a gamechanger for Parkinson’s treatment?
What does the ‘Cures Act’ mean for people with Parkinson’s?
3 weeks ago
Acupuncture may alleviate Parkinson’s symptoms
A study conducted by researchers in South Korea has found that acupuncture may help alleviate motor symptoms of Parkinson’s. The study – published in science journal ‘Frontiers in Aging Neuroscience’ – collected data from 42 existing trials testing the effects of acupuncture on different mouse models of Parkinson’s disease. A total of 40 studies showed that acupuncture increased levels of tyrosine hydroxylase – an enzyme in the brain which is part of the dopamine-producing process. Although there was no evidence to suggest acupuncture can induce changes in dopamine levels, results suggested that acupuncture may help alleviate motor symptoms in mice. Discussing their findings, the researchers commented: “Acupuncture treatment potentially protected [dopamine] neurons through various beneficial mechanisms. “Nevertheless, resolving the low quality of studies and further research investigating the efficacy of different acupuncture treatment methods in Parkinson’s disease rodent models will be needed.”
Could insulin be used to treat Parkinson’s symptoms?
A US study has found that intranasal insulin, which is commonly used to treat diabetes, may be able to improve Parkinson’s symptoms. As part of the study, published in scientific journal ‘PLOS ONE’, 14 people with Parkinson’s were administered a daily dose of intranasal insulin for four weeks. After the four week period, researchers – made up staff from Harvard Medical School, US, and the University of Massachusetts, US – saw an improvement in both the participants motor skills and verbal fluency. Discussing the trial, the researchers said: “Our study provided preliminary data that suggested an improvement of functional skills after four weeks of daily INI [intranasal insulin] treatment. That paves the way toward a larger cohort study to evaluate long-term safety and potential efficacy of intranasal insulin administration for potential treatment and prevention of functional decline in patients with Parkinson disease”.
Can drinking milk increase the risk of Parkinson’s?
Researchers at Uppsala University, Sweden, have found that drinking more than 40 millilitres of milk per day may increase the risk of developing Parkinson’s. As part of the study, 81,889 participants between the ages of 45 and 83 who do not live with the condition completed a survey detailing their milk, soured milk and yoghurt consumption. After an average follow up of 14 years, a total of 1,251 participants reported a Parkinson’s diagnosis. The dietary patterns of the participants showed that individuals who drank 40 to 159 millilitres of milk per day were 30% more likely to develop the condition. The researchers – who presented their study at the 2019 International Conference on Alzheimer’s and Parkinson’s Diseases in Lisbon, Portugal – concluded: “Findings from this cohort study indicate that consumption of milk, but not soured milk and yogurt, is associated with an increased risk of Parkinson’s disease.”